Mazisotine not checked

Eli Lilly · LY3556050 · CNTX-0290

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
8 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Osteoarthritis, Knee, Diabetic Neuropathic Pain, Chronic Low-back Pain
Main trialPhase 2
“The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.”In the company’s words, NCT05986292 on ClinicalTrials.gov
Other names
LY3556050 · CNTX-0290

Other drugs for Osteoarthritis, Knee

All 34 drugs for Osteoarthritis, Knee

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Apr 2027 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2Completed 21 Oct 2021 Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis
Phase 2Completed 9 Feb 2022 Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain
Phase 2Terminated 13 Jun 2022 Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2Completed 11 Jun 2025 A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Phase 1Completed 2 Jun 2017 A Study of Single and Repeated Doses of LY3556050 in Healthy Participants
Phase 1Completed 27 Dec 2022 A Study of Effect of LY3556050 on Metformin in Healthy Participants
Phase 1Completed 4 Nov 2023 A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Mazisotine

Following is part of Solo: you see every change to Mazisotine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in